GlassScriptPhysician profile
Kenneth Weisiger
NPI 1376504670
$11,341.57
in general payments reported to CMS, 2019-2025
20 companies · $451 in 2025
The $451 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,587 · 2020: $4,733 · 2021: $1,786 · 2022: $534 · 2023: $236 · 2024: $14.40 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $701.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $8,813.87 | 2019-2021 | |
| Glaxosmithkline, LLC. | $906.08 | 2019-2023 | Nucala |
| Grifols USA, LLC | $524.90 | 2019-2025 | Prolastin-C Liquid |
| Sunovion Pharmaceuticals INC. | $234.80 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $209.25 | 2019-2025 | Fasenra |
| Pulmonx Corporation | $115.25 | 2020 | |
| Electromed, INC. | $113.12 | 2025 | Smartvest |
| Inspire Medical Systems, INC. | $79.18 | 2023 | Inspire |
| Inogen, INC. | $48.13 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.52 | 2020-2025 | Glassia |
| Advanced Respiratory, INC | $41.46 | 2019 | |
| Nestle Healthcare Nutrition INC. | $36.28 | 2022 | |
| Philips North America LLC | $34.48 | 2019-2021 | |
| Circassia INC. | $31.54 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $22.94 | 2025 | Lumryz |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Breathe Technologies, INC. | $20.79 | 2019 | |
| Ani Pharmaceuticals, INC. | $20.00 | 2025 | Purified Cortrophin Gel |
| Mallinckrodt Enterprises LLC | $18.55 | 2019 | |
| Jazz Pharmaceuticals INC. | $14.82 | 2025 | |
| Resmed Corp | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Weisiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.